trending Market Intelligence /marketintelligence/en/news-insights/trending/a3xkhj0MeWqbNtVJiP6VOQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Lupin launches generic female contraceptive in US

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Video

Climate Credit Analytics: Linking climate scenarios to financial impacts

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


Lupin launches generic female contraceptive in US

Lupin Ltd. launched a generic version of Janssen Pharmaceuticals Inc.'s female contraceptive tablet Ortho-Cyclen.

The norgestimate and ethinyl estradiol tablets are approved by the U.S. FDA. Ortho-Cyclen generated $204 million in U.S. sales during the 12 months ended September 2016, according to IMS Health data.

Janssen Pharmaceuticals is a Johnson & Johnson unit.